OPKO Health, Inc. (OPK)

NasdaqGS • Currently down 0.02 (-1.14%) in today's trading session

1 member of Congress has disclosed 6 trades in OPKO Health, Inc. (OPK) via STOCK Act filings. The most recent disclosure was a purchase by Carlos Curbelo on 26 September 2017. Aggregate disclosed activity totals roughly $48K in purchases (midpoint estimates from bracketed disclosure amounts).

OPKO Health, Inc. is currently trading at $1.73, positioned at 85% of its 52-week range ($0.98 – $1.86).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$1.73
24h Change
-0.02 (-1.14%)
52 Week Range
$0.98–$1.86
View on NASDAQ

OPKO Health, Inc. Price History and Technical Analysis

Congressional Trading Activity for OPK

Select to highlight on chart
5 transactions
Compliance: 50%
Carlos Curbelo26 Sept 20173 Oct 2017PurchaseStock$1,001 - $15,000N/A
Carlos Curbelo26 Sept 201713 Aug 2018PurchaseStock$1,001 - $15,000N/A
Carlos Curbelo2 Mar 20172 Mar 2017PurchaseStock$1,001 - $15,000N/A
Carlos Curbelo2 Mar 201713 Aug 2018PurchaseStock$1,001 - $15,000N/A
Carlos Curbelo7 Feb 20177 Feb 2017PurchaseStock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$1.29B

Volume

6.9M

Beta

1.52

P/E Ratio

-19.22

Fundamentals

EPS

$-0.09

Div. Yield

-

Open

$1.77

Day Range

$1.72 – $1.86

Company Information

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ · USD
Country
US
CEO
Phillip Frost
IPO Date
1995-11-02
Website
www.opko.com

OPKO Health, Inc. operates as a healthcare enterprise with a dual focus on diagnostics and pharmaceuticals. Its operations span the United States, Ireland, Chile, Spain, Israel, Mexico, and other international markets. The company's Diagnostics divis...

Earnings

Next Report

Q4 2026

25 Feb

EPS Est.

$-0.08

Rev. Est.

$133.2M

Days Until

108

Recent Quarters

Q3 20264 Nov
EPS$-0.05
Beat 26.5%
Q2 202627 Jul
EPS$-0.01
Beat 87.5%
Q1 202628 Apr
EPS$-0.07
Beat 0.0%
Q4 202526 Feb
EPS$-0.04
Beat 42.9%
Q3 202529 Oct
EPS$0.03
Beat 250.0%
Q2 202531 Jul
EPS$-0.19
Miss 58.3%
Q1 202530 Apr
EPS$-0.10
Miss 66.7%
Q4 202427 Feb
EPS$0.01
Beat 112.5%
Q3 20247 Nov
EPS$0.03
Beat 130.0%
Q2 20247 Aug
EPS$-0.01
Beat 88.9%
Q1 20247 May
EPS$-0.12
Miss 33.3%
Q4 202327 Feb
EPS$-0.09
Beat 0.0%
Q3 20236 Nov
EPS$-0.11
Miss 22.2%
Q2 20233 Aug
EPS$-0.03
Beat 57.1%
Q1 20233 May
EPS$-0.02
Beat 71.4%
Q4 202223 Feb
EPS$-0.11
Beat 0.0%
Q3 20228 Nov
EPS$-0.11
Miss 10.0%
Q2 20224 Aug
EPS$-0.14
Miss 600.0%
Q1 20229 May
EPS$-0.08
Beat 0.0%
Q4 202124 Feb
EPS$-0.11
Miss 450.0%
Q3 202128 Oct
EPS$0.04
Beat 100.0%
Q2 202129 Jul
EPS$-0.03
Miss 155.5%
Q1 202128 Apr
EPS$0.05
Beat 0.0%
Q4 202018 Feb
EPS$0.05
Beat 19.1%
Q3 202029 Oct
EPS$0.04
Miss 9.1%
Q2 202030 Jul
EPS$0.05
Beat 171.4%
Q1 20206 May
EPS$-0.09
Beat 0.0%
Q4 201926 Feb
EPS$-0.06
Beat 25.0%
Q3 20195 Nov
EPS$-0.11
Miss 22.2%
Q2 20197 Aug
EPS$-0.10
Beat 9.1%
Q1 20197 May
EPS$-0.14
Miss 100.0%
Q4 201827 Feb
EPS$-0.08
Beat 11.1%
Q3 20189 Nov
EPS$-0.05
Beat 37.5%
Q2 20187 Aug
EPS$-0.04
Beat 42.9%
Q1 20188 May
EPS$-0.08
Beat 42.9%
Q4 20171 Mar
EPS$-0.12
Miss 50.0%
Q3 20178 Nov
EPS$-0.08
Miss 60.0%
Q2 20178 Aug
EPS$-0.04
Beat 20.0%
Q1 20179 May
EPS$-0.06
Miss 20.0%
Q4 20161 Mar
EPS$-0.04
Beat 20.0%
Q3 20167 Nov
EPS$-0.03
Beat 40.0%
Q2 20168 Aug
EPS$0.02
Q1 20169 May
EPS$-0.02
Miss 11.7%
Q4 201529 Feb
EPS$0.00
Q3 20159 Nov
EPS$0.25
Beat 271.5%
Q2 20155 Aug
EPS$-0.04
Beat 33.3%
Q1 201511 May
EPS$-0.08
Beat 0.0%
Q4 201427 Feb
EPS$-0.12
Miss 71.4%
Q3 20147 Nov
EPS$-0.11
Miss 37.5%
Q2 201411 Aug
EPS$-0.04
Beat 55.6%
Q1 20149 May
EPS$-0.09
Beat 10.0%
Q4 20133 Mar
EPS$-0.04
Beat 33.3%
Q3 201311 Nov
EPS$-0.09
Miss 28.6%
Q2 20139 Aug
EPS$-0.04
Beat 33.3%
Q1 201310 May
EPS$-0.06
Miss 25.0%
Q4 201218 Mar
EPS$-0.00
Miss 66.7%
Q3 20129 Nov
EPS$-0.03
Beat 0.0%
Q2 20129 Aug
EPS$-0.04
Miss 33.3%
Q1 201210 May
EPS$-0.03
Miss 20.0%
Q4 201115 Mar
EPS$0.06
Beat 220.0%
Q3 20119 Nov
EPS$-0.03
Miss 50.0%
Q2 20118 Aug
EPS$-0.02
Beat 49.5%
Q1 20119 May
EPS$-0.02
Beat 27.0%
Q4 201016 Mar
EPS$-0.00
Q3 20109 Nov
EPS$-0.03
Q2 20109 Aug
EPS$-0.02
Beat 19.0%
Q1 201010 May
EPS$-0.02
Q4 200917 Mar
EPS$-0.04
Q3 20096 Nov
EPS$-0.03
Q2 20097 Aug
EPS$-0.03
Q1 20098 May
EPS$-0.05
Q4 200816 Mar
EPS$-0.05
Q3 200810 Nov
EPS$-0.04
Q2 20088 Aug
EPS$-0.06
Q1 200814 May
EPS$-0.06
Q4 200731 Mar
EPS$-0.05
Q3 200714 Nov
EPS$0.01
Q2 200713 Aug
EPS$-0.09
Q1 200716 May
EPS$-3.87
Q4 200622 Mar
EPS$-0.01
Q3 200614 Nov
EPS$-0.00
Q2 200614 Aug
EPS$-0.00
Q1 200615 May
EPS$-0.00
Q4 200531 Mar
EPS$-0.02
Q3 200514 Nov
EPS$0.05
Q2 200515 Aug
EPS$-0.03
Q1 200516 May
EPS$-0.02
Q1 200522 Apr
EPS$-0.02
Q3 200415 Nov
EPS$-0.02
Q2 200416 Aug
EPS$-0.03
Q1 200414 May
EPS$-0.05
Q1 20047 Apr
EPS$-0.09
Q3 200314 Nov
EPS$-0.10
Q2 200313 Aug
EPS$-0.11
Q1 200313 May
EPS$-0.06
Q4 200220 Mar
EPS$-0.26
Q3 200214 Nov
EPS$-0.17
Q2 20029 Aug
EPS$-0.12
Q1 200210 May
EPS$-0.11
Q1 20022 Apr
EPS$-0.12
Beat 20.0%
Q3 200124 Oct
EPS$-0.18
Miss 12.5%
Q2 200115 Aug
EPS$-0.18
Miss 800.0%
Q1 200115 May
EPS$-0.08
Q1 20011 Apr
EPS$-0.10
Beat 9.1%
Q3 200014 Nov
EPS$-0.13
Q2 200014 Aug
EPS$-0.09
Q1 200015 May
EPS$-0.22
Q4 199930 Mar
EPS$-0.13
Q3 199915 Nov
EPS$-0.10
Q2 199916 Aug
EPS$-0.08
Q1 199917 May
EPS$-0.11
Q4 199831 Mar
EPS$-0.08
Q3 199813 Nov
EPS$-0.10
Q2 199814 Aug
EPS$-0.02
Q1 199815 May
EPS$-0.10
Q3 199731 Dec
EPS$-0.10
Q3 199713 Nov
EPS$-0.12
Q2 199713 Aug
EPS$-0.10
Q1 199715 May
EPS$-0.10
Q1 19976 May
EPS$-0.11
Q3 199614 Nov
EPS$-0.12
Q2 199614 Aug
EPS$-0.10
Q1 199613 May
EPS$-0.13

2 politicians traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

GE

GE Aerospace

17
$323.24+8.51 (+2.70%)
Industrials
Held by same politician
1 politician
View Stock

ORLY

O'Reilly Automotive, Inc.

17
$89.89-1.60 (-1.75%)
Consumer Cyclical
Held by same politician
1 politician
View Stock

V

Visa Inc.

17
$422.65+0.06 (+0.01%)
Financial Services
Held by same politician
1 politician
View Stock

Frequently Asked Questions about OPK

Which members of Congress have traded OPK?
1 member of Congress has disclosed 6 trade in OPKO Health, Inc. (OPK) under the STOCK Act: Carlos Curbelo.
When was OPK most recently disclosed by Congress?
The most recent OPK disclosure was a purchase by Carlos Curbelo on 26 September 2017.
What is the total disclosed congressional trading volume for OPK?
Members of Congress have disclosed approximately $48K in OPK purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in OPK?
This OPK page updates as soon as new STOCK Act disclosures are filed for OPKO Health, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.